µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
D83 °øÅë°¡º¯¼º ¸é¿ª°áÇÌÁõ Common variable immunodeficiency
D830 B¼¼Æ÷ ¼ö ¹× ±â´ÉÀÇ ÇöÀúÇÑ ÀÌ»ó¿¡ ÀÇÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D831 ÇöÀúÇÑ ¸é¿ªÁ¶ÀýT¼¼Æ÷ Àå¾Ö¿¡ ÀÇÇÑ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
D832 B ¶Ç´Â T¼¼Æ÷¿¡ ´ëÇÑ ÀÚ°¡Ç×ü¸¦ µ¿¹ÝÇÑ °øÅë °¡º¯¼º ¸é¿ª°áÇÌ Common variable immunodeficiency with autoantibodies to B-or T-cells
D838 ±âŸ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ Other common variable immunodeficiencies
D839 »ó¼¼ºÒ¸íÀÇ °øÅë°¡º¯¼º ¸é¿ª°áÇÌ Common variable immunodeficiency, unspecified
D84 ±âŸ ¸é¿ª°áÇÌ Other immunodeficiencies
D840 ¸²ÇÁ±¸±â´ÉÇ׿ø-1°á¼Õ Lymphocyte function antigen-1 [LFA-1] defect
D841 º¸Ã¼°èÅëÀÇ°á¼Õ Defects in the complement system
D841 C1¿¡½ºÅÍ·¹À̽º ¾ïÁ¦ÀÎÀÚ°áÇÌ C1 esterase inhibitor[C1-INH] dificiency
D848 ±âŸ ¸í½ÃµÈ ¸é¿ª°áÇÌ Other specified immunodeficiencies
D849 »ó¼¼ºÒ¸íÀÇ ¸é¿ª°áÇÌ Immunodeficiency, unspecified
D86 »ç¸£ÄÚÀ̵åÁõ Sarcoidosis
D860 ÆóÀÇ »ç¸£ÄÚÀ̵åÁõ Sarcoidosis of lung
D861 ¸²ÇÁÀýÀÇ »ç¸£ÄÚÀ̵åÁõ Sarcoidosis of lymph nodes
D862 ¸²ÇÁÀýÀÇ »ç¸£ÄÚÀ̵åÁõÀ» µ¿¹ÝÇÑ ÆóÀÇ »ç¸£ÄÚÀ̵åÁõ Sarcoidosis of lung with sarcoidosis of lymph nodes
D863 ÇǺÎÀÇ »ç¸£ÄÚÀ̵åÁõ Sarcoidosis of skin
D868 ±âŸ ¹× º¹ÇÕ ºÎÀ§ÀÇ »ç¸£ÄÚÀ̵åÁõ Sarcoidosis of other and combined sites
D868 »ç¸£ÄÚÀ̵åÁõ¿¡¼­ÀÇ È«Ã¤¼¶¸ðü¿° Iridocyclitis in sarcoidosis (H22.1*)
D868 »ç¸£ÄÚÀ̵åÁõ¿¡¼­ÀÇ ´Ù¹ß¼º ³ú½Å°æ¸¶ºñ Multiple cranial nerve palsies in sarcoidosis(G53.2*)
2191  2192  2193  2194  2195  [2196] 2197  2198  2199  2200